Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 14.40%5.68B | ---- | 20.70%11.22B | ---- | -4.64%4.97B | ---- | 8.96%9.3B | ---- | 9.57%5.21B |
| Profit adjustment | ||||||||||
| Interest expense - adjustment | ---- | -14.47%3.9B | ---- | -6.70%8.89B | ---- | 1.67%4.56B | ---- | 2.11%9.52B | ---- | -7.24%4.49B |
| Dividend (income)- adjustment | ---- | -3.32%-1.48B | ---- | -70.72%-2.97B | ---- | -83.17%-1.43B | ---- | -22.80%-1.74B | ---- | -13.75%-780.76M |
| Attributable subsidiary (profit) loss | ---- | 3.39%-725.94M | ---- | 3.35%-1.48B | ---- | 2.38%-751.39M | ---- | 7.66%-1.53B | ---- | 10.14%-769.71M |
| Impairment and provisions: | ---- | -141.82%-15.76M | ---- | -160.33%-113.3M | ---- | -74.37%37.69M | ---- | -38.91%187.82M | ---- | -30.77%147.07M |
| -Other impairments and provisions | ---- | -141.82%-15.76M | ---- | -160.33%-113.3M | ---- | -74.37%37.69M | ---- | -38.91%187.82M | ---- | -30.77%147.07M |
| Revaluation surplus: | ---- | 147.36%1.97B | ---- | 50.59%-1.21B | ---- | -141.07%-4.15B | ---- | -180.59%-2.44B | ---- | -247.45%-1.72B |
| -Derivative financial instruments fair value (increase) | ---- | 160.12%1.71B | ---- | 57.43%486.82M | ---- | -992.10%-2.85B | ---- | 118.32%309.23M | ---- | -123.80%-260.73M |
| -Other fair value changes | ---- | 119.48%253.94M | ---- | 38.44%-1.69B | ---- | 10.77%-1.3B | ---- | -158.31%-2.75B | ---- | -2,115.76%-1.46B |
| Asset sale loss (gain): | ---- | -75.61%-625.64M | ---- | -704.31%-706.49M | ---- | -1,080.61%-356.27M | ---- | -148.45%-87.84M | ---- | -115.83%-30.18M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.07M | ---- | ---1.07M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -1,122.47%-1.09M | ---- | -115.73%-2.35M | ---- | 89.26%-89K | ---- | -142.64%-1.09M | ---- | 15.67%-829K |
| -Loss (gain) from selling other assets | ---- | -75.35%-624.55M | ---- | -721.78%-704.15M | ---- | -1,159.40%-356.18M | ---- | -147.93%-85.69M | ---- | -114.76%-28.28M |
| Depreciation and amortization: | ---- | 6.21%448.51M | ---- | 12.89%864.98M | ---- | 12.22%422.28M | ---- | 9.85%766.25M | ---- | 10.47%376.28M |
| -Depreciation | ---- | 6.21%448.51M | ---- | 12.89%864.98M | ---- | 12.22%422.28M | ---- | 9.85%766.25M | ---- | 10.47%376.28M |
| Exchange Loss (gain) | ---- | 516.96%43.34M | ---- | -242.70%-113.7M | ---- | -106.13%-10.4M | ---- | 29.70%79.68M | ---- | 9.26%169.68M |
| Operating profit before the change of operating capital | ---- | 179.36%9.2B | ---- | 2.33%14.38B | ---- | -53.55%3.29B | ---- | -26.27%14.05B | ---- | -29.93%7.09B |
| Change of operating capital | ||||||||||
| Accounts payable increase (decrease) | ---- | 32.02%-17.67B | ---- | 228.19%33.61B | ---- | -438.46%-25.99B | ---- | 134.09%10.24B | ---- | -25.17%7.68B |
| Financial assets at fair value (increase)decrease | ---- | -133.83%-11.99B | ---- | 165.74%24.13B | ---- | 217.49%35.44B | ---- | -182.98%-36.7B | ---- | -234.14%-30.17B |
| Buy and sell back financial assets (increase) decrease | ---- | -50.22%7.04B | ---- | 5,345.30%17.79B | ---- | 16.71%14.14B | ---- | 96.77%-339.2M | ---- | 55.76%12.11B |
| Special items for working capital changes | ---- | 67.77%32.29B | ---- | -289.85%-63.27B | ---- | 11.14%19.25B | ---- | 1,033.68%33.33B | ---- | 640.21%17.32B |
| Cash from business operations | ---- | -59.08%18.87B | ---- | 29.41%26.63B | ---- | 228.66%46.13B | ---- | -65.75%20.58B | ---- | -70.42%14.03B |
| Other taxs | ---- | -201.36%-156M | ---- | 96.73%-16.32M | ---- | 158.78%153.91M | ---- | 61.06%-498.42M | ---- | 58.07%-261.84M |
| Interest paid - operating | ---- | 23.64%-1.68B | ---- | -1.01%-4.36B | ---- | -5.42%-2.19B | ---- | -23.08%-4.31B | ---- | -8.39%-2.08B |
| Adjustment items of business operations | -121.38%-16.34B | ---- | -660.30%-37.21B | ---- | 506.00%76.4B | ---- | -73.14%6.64B | ---- | -50.48%12.61B | ---- |
| Net cash from operations | -121.38%-16.34B | -61.34%17.04B | -660.30%-37.21B | 41.17%22.26B | 506.00%76.4B | 277.10%44.09B | -73.14%6.64B | -71.49%15.77B | -50.48%12.61B | -73.96%11.69B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 4.85%2.89B | 9.10%2.19B | -1.52%646.59M | 50.80%3.54B | 52.84%2.76B | 45.45%2.01B | 66.15%656.58M | 12.25%2.35B | 6.25%1.81B | 7.18%1.38B |
| Sale of fixed assets | --1.4M | 407.35%1.38M | --1.22M | 39.63%6.49M | ---- | 23.08%272K | ---- | 185.28%4.65M | ---- | -78.23%221K |
| Purchase of fixed assets | 30.85%-216.99M | 32.43%-107.81M | 67.00%-21.66M | -25.56%-763.71M | -29.77%-313.8M | -6.36%-159.55M | -17.64%-65.64M | -8.57%-608.24M | 16.09%-241.81M | -0.13%-150.01M |
| Recovery of cash from investments | --7.88B | ---- | --14.94B | ---- | ---- | ---- | ---- | -56.99%3.1M | --2.4M | --3.47M |
| Cash on investment | 99.84%-21.43M | 192.38%11.53B | 99.80%-21.53M | 34.04%-17.05B | -728.01%-13.54B | -14,011.10%-12.48B | ---11.03B | -25.02%-25.84B | 83.71%-1.64B | 100.58%89.7M |
| Other items in the investment business | ---- | ---- | ---- | ---- | 45.68%353.62K | ---- | 104.83%134.4K | ---- | -82.81%242.75K | ---- |
| Net cash from investment operations | 194.96%10.54B | 228.09%13.61B | 248.89%15.54B | 40.81%-14.26B | -15,963.60%-11.1B | -902.27%-10.63B | -486.03%-10.44B | -25.95%-24.09B | 99.20%-69.09M | 109.27%1.32B |
| Net cash before financing | -108.88%-5.8B | -8.37%30.66B | -470.57%-21.67B | 196.09%8B | 420.82%65.3B | 157.06%33.46B | -113.85%-3.8B | -123.02%-8.33B | -25.49%12.54B | -57.47%13.02B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | 232.85%5.03B | 130.46%1.65B | -73.10%195.35M | ---- | -179.99%-3.79B | 732.04%716.4M | --726.1M |
| Refund | 25.53%-97.4B | -151.15%-1.26B | 13.20%-40.93B | ---- | -35.26%-130.8B | 90.30%-500.7M | -49.05%-47.15B | ---- | -36.54%-96.7B | 67.83%-5.16B |
| Issuance of bonds | 24.94%104.65B | -31.68%39.58B | -3.51%21.26B | 8.26%148.41B | -0.44%83.76B | 39.16%57.94B | 164.30%22.03B | 59.20%137.08B | 22.51%84.13B | 4.81%41.64B |
| Interest paid - financing | ---- | 27.29%-2.2B | ---- | 12.17%-5.3B | ---- | 18.53%-3.02B | ---- | -5.20%-6.03B | ---- | -5.25%-3.71B |
| Dividends paid - financing | -0.94%-8.02B | 0.00%-572.24M | 30.66%-1.05B | -66.34%-3.65B | -4.69%-7.95B | 0.00%-572.24M | 39.47%-1.52B | 60.20%-2.19B | 26.67%-7.59B | 28.66%-572.24M |
| Absorb investment income | --2B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 21.97%-69.61B | ---- | -32.06%-154.52B | ---- | -69.62%-89.21B | ---- | -37.23%-117.01B | ---- | -26.84%-52.59B |
| Other items of the financing business | 6.81%-263.8M | ---- | 11.36%-87.32M | ---- | 5.45%-283.07M | ---- | -2.94%-98.51M | ---- | 98.04%-299.38M | ---- |
| Net cash from financing operations | 101.81%968.13M | 3.17%-34.21B | 22.17%-20.81B | -234.50%-10.36B | -171.54%-53.62B | -78.09%-35.33B | -3.22%-26.74B | 136.65%7.7B | -55.57%-19.75B | 10.85%-19.84B |
| Effect of rate | -323.04%-116.7M | -114.02%-8.11M | -1,099.44%-53.32M | -24.58%135.24M | -86.72%52.32M | -83.61%57.84M | 102.06%5.33M | -61.86%179.31M | -59.59%393.96M | 714.19%352.95M |
| Net Cash | -141.32%-4.83B | -89.79%-3.55B | -39.12%-42.48B | -277.45%-2.36B | 262.11%11.68B | 72.55%-1.87B | -2,103.02%-30.54B | -104.12%-624.67M | -274.31%-7.21B | -181.69%-6.82B |
| Begining period cash | 20.76%176.64B | -7.46%27.56B | 20.76%176.64B | -1.47%29.78B | 8.12%146.27B | -1.47%29.78B | 8.12%146.27B | 107.07%30.23B | 21.07%135.28B | 107.07%30.23B |
| Cash at the end | 8.66%171.69B | -14.20%24B | 15.87%134.11B | -7.46%27.56B | 22.99%158.01B | 17.72%27.97B | -15.24%115.74B | -1.47%29.78B | 9.95%128.47B | 3.32%23.76B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.